Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide adjunctive therapy in uncontrolled primary generalized tonic-clonic seizures
CTR20160911Phase 3Completed
- Sponsor
- UCB
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lacosamide in idiopathic epilepsy (IGE), sponsored by UCB. Started Dec 2017; status: completed.
02
Drugs
lacosamide
03
Conditions
idiopathic epilepsy (IGE)
Beyond the preview
Go deeper on CTR20160911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160911.